A deletion of 11 bp (CD 131-134) in exon 3 of the beta-globin gene produces the phenotype of inclusion body beta-thalassemia

Ann Hematol. 2005 Sep;84(9):584-7. doi: 10.1007/s00277-004-0992-2. Epub 2005 Jun 24.

Abstract

Dominant inherited beta-thalassemias describe those beta-thalassemia variants that result in a thalassemia intermediate phenotype in individuals who have inherited only a single copy of the abnormal beta gene. This form of thalassemia is characterized by moderately severe anemia with jaundice and splenomegaly; it is also characterized by the presence of inclusion bodies in the red blood cell precursors and has, therefore, previously been referred to as inclusion body beta-thalassemia. We describe a case of inclusion body beta-thalassemia in a 51-year-old Spanish male caused by a deletion of 11 bp (CD 131-134) in exon 3 of the beta-globin gene. The deletion of 11 bp in exon 3 of the beta-globin chain is predicted to produce an anomalous chain of 134 amino acids instead of the normal 146 with an extremely altered amino acid sequence from residues 131-134. Although this shortened variant would lead to a missing H helix, which is involved in alpha1beta1 contact and alpha1beta2 subunit interactions, the variant chain can still be bound to the heme group and acquire a secondary structure that is not suitable for the formation of stable dimers or tetramers and also less susceptible to proteolytic degradation. This is the first report of such a beta-thalassemia mutation.

Publication types

  • Case Reports

MeSH terms

  • DNA Mutational Analysis
  • Exons*
  • Frameshift Mutation
  • Genes, Dominant
  • Globins / genetics*
  • Heme
  • Hemoglobins, Abnormal / chemistry
  • Hemoglobins, Abnormal / genetics
  • Humans
  • Inclusion Bodies / pathology*
  • Male
  • Middle Aged
  • Peptide Hydrolases / metabolism
  • Phenotype
  • Protein Structure, Secondary
  • Sequence Deletion*
  • beta-Thalassemia / genetics*
  • beta-Thalassemia / pathology

Substances

  • Hemoglobins, Abnormal
  • Heme
  • Globins
  • Peptide Hydrolases